These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 27930641

  • 1. Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is not necessary, at least in induction.
    Chiaretti S.
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):892-896. PubMed ID: 27930641
    [No Abstract] [Full Text] [Related]

  • 2. Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is the best treatment for these patients.
    Short NJ, Jabbour E.
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):892-894. PubMed ID: 27930640
    [No Abstract] [Full Text] [Related]

  • 3. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
    Fathi AT, DeAngelo DJ, Stevenson KE, Kolitz JE, Asch JD, Amrein PC, Attar EC, Steensma DP, Wadleigh M, Foster J, Connolly C, Galinsky I, Devoe CE, Stone RM, Neuberg DS, Ballen KK.
    Cancer; 2016 Aug 01; 122(15):2379-88. PubMed ID: 27171984
    [Abstract] [Full Text] [Related]

  • 4. New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Saini L, Brandwein J.
    Curr Hematol Malig Rep; 2017 Apr 01; 12(2):136-142. PubMed ID: 28243848
    [Abstract] [Full Text] [Related]

  • 5. First-line treatment of acute lymphoblastic leukaemia in children.
    Prescrire Int; 2015 Feb 01; 24(157):39. PubMed ID: 25802913
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
    Takeuchi J.
    Rinsho Ketsueki; 2010 Jul 01; 51(7):460-3. PubMed ID: 20693763
    [No Abstract] [Full Text] [Related]

  • 7. [Management of acute lymphoblastic leukemia].
    Usui N.
    Rinsho Ketsueki; 2008 Oct 01; 49(10):1374-85. PubMed ID: 18833922
    [No Abstract] [Full Text] [Related]

  • 8. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
    Wang J, Huang X, Jiang B, Qin Y, Bao L, Jiang H, Chen H, Jia J, Yang S, Jiang Q.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb 01; 35(2):120-5. PubMed ID: 24606652
    [Abstract] [Full Text] [Related]

  • 9. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
    Carella AM.
    Haematologica; 1992 Feb 01; 77(4):348-51. PubMed ID: 1358772
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Ribera JM, García O, Gil C, Mercadal S, García-Cadenas I, Montesinos P, Barba P, Vives S, González-Campos J, Tormo M, Esteve J, López A, Moreno MJ, Ribera J, Alonso N, Bermúdez A, Amigo ML, Genescà E, García D, Vall-Llovera F, Bergua JM, Guàrdia R, Monteserín MC, Bernal T, Calbacho M, Martínez MP, Feliu E, PETHEMA Group.
    Leuk Res; 2018 May 01; 68():79-84. PubMed ID: 29574396
    [Abstract] [Full Text] [Related]

  • 11. [Treatment strategy for childhood and adolescent acute lymphoblastic leukemia in first remission].
    Hori H.
    Rinsho Ketsueki; 2010 Jul 01; 51(7):454-9. PubMed ID: 20693762
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M, Mayer J, Korístek Z, Protivánková M, Brychtová Y, Oborilová A, Král Z, Klabusay M, Tomíska M, Buchtová I, Vorlícek J.
    Cas Lek Cesk; 2002 Mar 01; 141(4):122-6. PubMed ID: 12046256
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M, Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG), Tokyo, Japan.
    Jpn J Clin Oncol; 2012 May 01; 42(5):394-404. PubMed ID: 22422899
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of adult Ph-negative acute lymphoblastic leukemia].
    Imai K.
    Rinsho Ketsueki; 2014 Oct 01; 55(10):1962-71. PubMed ID: 25297761
    [No Abstract] [Full Text] [Related]

  • 15. [Acute lymphoblastic leukemia and chronic lymphocytic leukemia in adults].
    Usui N.
    Rinsho Ketsueki; 2012 Feb 01; 53(2):164-75. PubMed ID: 22450575
    [No Abstract] [Full Text] [Related]

  • 16. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
    de Bont JM, Holt Bv, Dekker AW, van der Does-van den Berg A, Sonneveld P, Pieters R.
    Leukemia; 2004 Dec 01; 18(12):2032-5. PubMed ID: 15483674
    [No Abstract] [Full Text] [Related]

  • 17. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Daver N, Thomas D, Ravandi F, Cortes J, Garris R, Jabbour E, Garcia-Manero G, Borthakur G, Kadia T, Rytting M, Konopleva M, Kantarjian H, O'Brien S.
    Haematologica; 2015 May 01; 100(5):653-61. PubMed ID: 25682595
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.